Patents by Inventor Toshinobu MAKI

Toshinobu MAKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for treating retinopathy
    Patent number: 10821126
    Abstract: It is to provide an agent for treating and/or ameliorating retinopathy caused by glucose. It is an agent for treating retinopathy caused by glucose comprising sodium/glucose cotransporter2 inhibitor (SGLT2 inhibitor) as an active ingredient, and is used at a normal dosage amount, or at a lower dosage whereby no lowering in blood sugar is observed.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: November 3, 2020
    Assignee: CARNA HEALTH SUPPORT LTD.
    Inventors: Toyoshi Inoguchi, Yasutaka Maeda, Toshinobu Maki, Noriyuki Sonoda
  • AGENT FOR TREATING RETINOPATHY
    Publication number: 20190240243
    Abstract: It is to provide an agent for treating and/or ameliorating retinopathy caused by glucose. It is an agent for treating retinopathy caused by glucose comprising sodium/glucose cotransporter2 inhibitor (SGLT2 inhibitor) as an active ingredient, and is used at a normal dosage amount, or at a lower dosage whereby no lowering in blood sugar is observed.
    Type: Application
    Filed: December 9, 2016
    Publication date: August 8, 2019
    Applicant: CARNA HEALTH SUPPORT LLC.
    Inventors: Toyoshi INOGUCHI, Yasutaka MAEDA, Toshinobu MAKI, Noriyuki SONODA